Search results
Biogen (BIIB) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 1 year agoBiogen's (BIIB) sales in the first quarter are likely to have been hurt by lower sales of multiple...
Can Biogen (BIIB) Keep the Beat Streak Alive in Q4 Earnings?
Zacks via Yahoo Finance· 4 months agoBiogen's (BIIB) sales in the fourth quarter are likely to have been hurt by lower sales of its...
Biogen (BIIB) Q1 Earnings Beat, Stock Up on Alzheimer Drug Uptake
Zacks via Yahoo Finance· 2 months agoBiogen's (BIIB) first-quarter earnings beat estimates but sales miss the mark. While sales of key...
Biogen Inc. (BIIB) Down 2.3% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 1 year agoA month has gone by since the last earnings report for Biogen Inc. (BIIB). Shares have lost about...
Biogen's Turnaround Is Still Waiting In The Wings As Aduhelm Pressures Continue
Investor's Business Daily· 4 months agoBiogen's turnaround is still a "work in progress," an analyst said Tuesday as Biogen stock slumped...
Biogen Is Suffering From Doubts About the Future
GuruFocus.com via Yahoo Finance· 2 months agoBiogen Inc. (NASDAQ:BIIB) is an American biopharmaceutical company specializing in the development and commercialization of biosimilars and medicines...
What's in Store for Biogen (BIIB) This Earnings Season?
Zacks via Yahoo Finance· 2 months agoBiogen's (BIIB) sales in the first quarter are likely to have been hurt by lower sales of its...
Biogen Slumps On Limited Alzheimer's Sales Expectations As Pressure Points Mount
Investor's Business Daily· 1 year agoBiogen stock was hamstrung Wednesday on a mixed 2023 outlook that assumes expenses for new...
Biogen Skids On 'Low-Quality' Beat, Cuts Profit Guidance Following Reata Buyout
Investor's Business Daily· 7 months agoBiogen stock skidded Wednesday on a "low-quality" sales beat that relied on other revenue. But...
Biogen (BIIB) Beats on Q1 Earnings, Ends Some Research Programs
Zacks via Yahoo Finance· 1 year agoBiogen BIIB reported first-quarter 2023 adjusted earnings per share (EPS) of $3.40, beating the...